Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Projets Transversaux
Projets
Publications
Télécharger-
2019Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot., Sci Transl Med 2019 10; 11(512): .
-
2019Immune parameters and outcomes during Ebola virus disease, JCI Insight 2019 Jan;4(1).
-
2015Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement, Clin. Infect. Dis. 2015 Nov;61(10):1627-8.
-
2015Towards deep insight into Ebola virus disease, Lancet Infect Dis 2015 Sep;15(9):991-992.
-
2015Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus, Curr Opin Virol 2015 Feb;10:70-6.
-
2015Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014, J. Clin. Virol. 2015 Jan;62:124-34.
-
2014Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014, Viruses 2014 Nov;6(11):4760-99.
-
2014Ebola: should we consider influenza vaccination?, Lancet 2014 Dec;384(9959):2023-4.
-
2014Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response, J. Virol. 2014 Dec;88(23):13923-7.
-
2014The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses, J. Virol. 2014 Dec;88(23):13811-20.
-
+Voir la liste complète de publications